Associated Papers
Retrospective Study of Trametinib in Patients With Advanced NF1-Mutant Melanoma.
Wang L et al.
Jco Precision Oncology, 2026
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML.
Ikoma Y et al.
Leukemia, 2025
40259101 (PubMed )
Supplement: 41375_2025_2625_MOESM2_ESM.xlsx › Sheet5
A microglia clonal inflammatory disorder in Alzheimer's disease.
Vicario R et al.
Elife, 2025
40085681 (PubMed )
Supplement: elife-96519-supp3.xlsx › ALL-SNV
Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
Kar SP et al.
Nature Genetics, 2022
35835912 (PubMed )
Supplement: 41588_2022_1121_MOESM3_ESM.xlsx › ST4
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Karachaliou GS et al.
Bmc Cancer, 2022
34986841 (PubMed )
Supplement: 12885_2021_8908_MOESM2_ESM.xlsx › APC_CTNNB1_wild_type
Genomic and transcriptomic landscape of conjunctival melanoma.
Cisarova K et al.
Plos Genetics, 2020
33383577 (PubMed )
Supplement: pgen.1009201.s006.xlsx › Sheet1
Desmoplastic melanoma with sarcomatoid dedifferentiation.
Kiuru M et al.
The American Journal of Surgical Pathology, 2014
Select a paper to view details